Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
74,89 USD | +1,53% | +5,23% | -5,91% |
29/04 | Axsome Therapeutics Fase 3 Alzheimer Behandelingstrial is Hoog Risico, Hoge Beloning, Morgan Stanley Zegt | MT |
29/04 | AXSOME THERAPEUTICS, INC. : Morgan Stanley zet aandeel op kooplijst | ZM |
Vakgebied
Aantal werknemers: 545
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Therapies
100,0
%
| 50 | 100,0 % | 271 | 100,0 % | +440,80% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
72,9
%
| 50 | 100,0 % | 197 | 72,9 % | +294,16% |
Non-United States
27,1
%
| - | - | 73 | 27,1 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 55 | 12-01-12 | |
Nick Pizzie
DFI | Director of Finance/CFO | 49 | 16-05-18 |
Mark Jacobson
COO | Chief Operating Officer | 40 | 01-04-14 |
Hunter Murdock
LAW | General Counsel | 44 | 01-12-21 |
Lori Englebert
PRN | Corporate Officer/Principal | 46 | 01-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Saad
BRD | Director/Board Member | 54 | 01-12-14 |
Susan Mahony
BRD | Director/Board Member | 60 | 11-10-23 |
Roger Jeffs
BRD | Director/Board Member | 62 | 01-12-14 |
Chief Executive Officer | 55 | 12-01-12 | |
Director/Board Member | 56 | 01-12-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 47 493 320 | 38 361 396 ( 80,77 %) | 0 | 80,77 % |
Bedrijfsgegevens
Axsome Therapeutics, Inc.
One World Trade Center 22nd floor
10007, New York
+212 332 3241
http://www.axsome.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,91% | 3,56 mld. | |
-3,93% | 86,16 mld. | |
+2,76% | 40,17 mld. | |
-16,48% | 31,47 mld. | |
+54,12% | 25,24 mld. | |
-13,58% | 15,82 mld. | |
-9,12% | 11,96 mld. | |
-42,56% | 11,61 mld. | |
+6,44% | 8,84 mld. | |
-1,99% | 7,93 mld. |
- Beurs
- Aandelen
- Koers AXSM
- Onderneming Axsome Therapeutics, Inc.